|Application:||ChIP-seq analysis, RNA-seq analysis|
|Number of samples:||82|
|Release date:||Jun 10 2016|
|Last update date:||Oct 18 2018|
|Diseases:||Neoplasms, Tooth, Impacted, Colorectal Neoplasms|
|Dataset link||Distinct gene regulatory programs define the inhibitory effects of LXRs and PPARG on cancer cell proliferation|
ChIP-seq and RNA-seq experiments were performed in HT29 cells using vehicle control (DMSO) or after drug treatment (GW3965 and rosiglitazone).
Richard M. Myers